Chemotherapy Stocks List

Chemotherapy Stocks Recent News

Date Stock Title
May 9 CHRS Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
May 9 KPTI Karyopharm Therapeutics Inc (KPTI) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 9 KPTI Q1 2024 Karyopharm Therapeutics Inc Earnings Call
May 8 CHRS Coherus BioSciences Q1 2024 Earnings Preview
May 8 KPTI Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
May 8 APLM Apollomics Announces Private Placement Financing and Addition to Board of Directors
May 8 KPTI Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
May 8 KPTI Karyopharm Therapeutics Inc. (KPTI) Q1 2024 Earnings Call Transcript
May 8 GLYC GlycoMimetics Q1 2024 Earnings Preview
May 8 KPTI Karyopharm announces significant refinancing transactions
May 8 KPTI Karyopharm Therapeutics Reports Q1 2024 Financial Results: A Detailed Review
May 8 CHRS When Can We Expect A Profit From Coherus BioSciences, Inc. (NASDAQ:CHRS)?
May 8 CHRS Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer
May 8 MBRX Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast
May 8 GLYC Uproleselan’s failed Phase III AML trial shakes up GlycoMimetics’ future
May 8 KPTI Karyopharm Therapeutics GAAP EPS of -$0.32 beats by $0.03, revenue of $33.13M misses by $1.34M
May 8 KPTI Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
May 8 KPTI Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 7 KPTI Karyopharm Therapeutics Q1 2024 Earnings Preview
May 7 MBRX Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data
Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim to prolong life or to reduce symptoms (palliative chemotherapy). Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.
The term chemotherapy has come to connote non-specific usage of intracellular poisons to inhibit mitosis, cell division. The connotation excludes more selective agents that block extracellular signals (signal transduction). The development of therapies with specific molecular or genetic targets, which inhibit growth-promoting signals from classic endocrine hormones (primarily estrogens for breast cancer and androgens for prostate cancer) are now called hormonal therapies. By contrast, other inhibitions of growth-signals like those associated with receptor tyrosine kinases are referred to as targeted therapy.
Importantly, the use of drugs (whether chemotherapy, hormonal therapy or targeted therapy) constitutes systemic therapy for cancer in that they are introduced into the blood stream and are therefore in principle able to address cancer at any anatomic location in the body. Systemic therapy is often used in conjunction with other modalities that constitute local therapy (i.e. treatments whose efficacy is confined to the anatomic area where they are applied) for cancer such as radiation therapy, surgery or hyperthermia therapy.
Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which may then lead to cell death if apoptosis is initiated. Many of the side effects of chemotherapy can be traced to damage to normal cells that divide rapidly and are thus sensitive to anti-mitotic drugs: cells in the bone marrow, digestive tract and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair loss). Because of the effect on immune cells (especially lymphocytes), chemotherapy drugs often find use in a host of diseases that result from harmful overactivity of the immune system against self (so-called autoimmunity). These include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, vasculitis and many others.

Browse All Tags